|
1
|
Byeon Y, Lee H Yool, Choi DW and Back K:
Chloroplast-encoded serotonin N-acetyltransferase in the red alga
Pyropia yezoensis: Gene transition to the nucleus from
chloroplasts. J Exp Bot. 66:709–717. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee MK, Kim IH, Choi YH, Choi JW, Kim YM
and Nam TJ: The proliferative effects of Pyropia yezoensis peptide
on IEC-6 cells are mediated through the epidermal growth factor
receptor signaling pathway. Int J Mol Med. 35:909–914.
2015.PubMed/NCBI
|
|
3
|
Wenz T, Rossi SG, Rotundo RL, Spiegelman
BM and Moraes CT: Increased muscle PGC-1alpha expression protects
from sarcopenia and metabolic disease during aging. Proc Natl Acad
Sci USA. 106:pp. 20405–20410. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Doherty TJ: Invited Review: Aging and
sarcopenia. J Appl Physiol (1985). 95:1717–1727. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marzetti E and Leeuwenburgh C: Skeletal
muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol.
41:1234–1238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dupont-Versteegden EE: Apoptosis in muscle
atrophy: Relevance to sarcopenia. Exp Gerontol. 40:473–481. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Artaza JN, Bhasin S, Mallidis C, Taylor W,
Ma K and Gonzalez-Cadavid NF: Endogenous expression and
localization of myostatin and its relation to myosin heavy chain
distribution in C2C12 skeletal muscle cells. J Cell Physiol.
190:170–179. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aoki MS, Miyabara EH, Soares AG, Saito ET
and Moriscot AS: mTOR pathway inhibition attenuates skeletal muscle
growth induced by stretching. Cell Tissue Res. 324:149–156. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weintraub H: The MyoD family and
myogenesis: Redundancy, networks, and thresholds. Cell.
75:1241–1244. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Melo F, Carey DJ and Brandan E:
Extracellular matrix is required for skeletal muscle
differentiation but not myogenin expression. J Cell Biochem.
62:227–239. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
te Pas MF, Soumillion A, Harders FL,
Verburg FJ, van den Bosch TJ, Galesloot P and Meuwissen TH:
Influences of myogenin genotypes on birth weight, growth rate,
carcass weight, backfat thickness, and lean weight of pigs. J Anim
Sci. 77:2352–2356. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sandri M, Sandri C, Gilbert A, Skurk C,
Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH and Goldberg
AL: Foxo transcription factors induce the atrophy-related ubiquitin
ligase atrogin-1 and cause skeletal muscle atrophy. Cell.
177:399–412. 2004. View Article : Google Scholar
|
|
13
|
Zhao W, Qin W, Pan J, Wu Y, Bauman WA and
Cardozo C: Dependence of dexamethasone-induced Akt/FOXO1 signaling,
upregulation of MAFbx, and protein catabolism upon the
glucocorticoid receptor. Biochem Biophys Res Commun. 378:668–672.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Glass DJ: Skeletal muscle hypertrophy and
atrophy signaling pathways. Int J Biochem Cell Biol. 37:1974–1984.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lecker SH, Jagoe RT, Gilbert A, Gomes M,
Baracos V, Bailey J, Price SR, Mitch WE and Goldberg AL: Multiple
types of skeletal muscle atrophy involve a common program of
changes in gene expression. FASEB J. 18:39–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng SJ and Yu LJ: Oxidative stress,
molecular inflammation and sarcopenia. Int J Mol Sci. 11:1509–1526.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi YH, Yamaguchi K, Oda T and Nam TJ:
Chemical and mass spectrometry characterization of the red alga
Pyropia yezoensis chemoprotective protein (PYP): Protective
activity of the N-terminal fragment of PYP1 against
acetaminophen-induced cell death in Chang liver cells. Int J Mol
Med. 35:271–276. 2015.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cooper ST, Maxwell AL, Kizana E, Ghoddusi
M, Hardeman EC, Alexander IE, Allen DG and North KN: C2C12
co-culture on a fibroblast substratum enables sustained survival of
contractile, highly differentiated myotubes with peripheral nuclei
and adult fast myosin expression. Cell Motil Cytoskeleton.
58:200–211. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gomes MD, Lecker SH, Jagoe RT, Navon A and
Goldberg AL: Atrogin1, a muscle-specific F-box protein highly
expressed during muscle atrophy. Proc Natl Acad Sci USA. 98:pp.
14440–14445. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Auclair D, Garrel DR, Zerouala A Chaouki
and Ferland LH: Activation of the ubiquitin pathway in rat skeletal
muscle by catabolic doses of glucocorticoids. Am J Physiol.
272:C1007–C1016. 1997.PubMed/NCBI
|
|
23
|
Jackman RW and Kandarian SC: The molecular
basis of skeletal muscle atrophy. Am J Physiol. 287:C834–C843.
2004. View Article : Google Scholar
|
|
24
|
Mitch WE and Goldberg AL: Mechanisms of
muscle wasting. The role of the ubiquitin-proteasome pathway. N
Engl J Med. 335:1897–1905. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krawiec BJ, Nystrom GJ, Frost RA,
Jefferson LS and Lang CH: AMP-activated protein kinase agonists
increase mRNA content of the muscle-specific ubiquitin ligases
MAFbx and MuRF1 in C2C12 cell. Am J Physiol Endocrinol Metab.
292:E1555–E1567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Clarke BA, Drujan D, Willis MS, Murphy LO,
Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Laltres E
and Glass DJ: The E3 ligase MuRF1 degrades myosin heavy chain
protein in dexamethasone-treated skeletal muscle. Cell Metab.
6:376–385. 2007. View Article : Google Scholar : PubMed/NCBI
|
